Clinical trials help us learn more about ways to prevent or treat medical conditions. Research must show a study medicine is safe and effective before it can be approved for use. Without these clinical research studies and the participants who take part in them, modern medicine would not exist.
We first test a study vaccine or study medicine with a small group of clinical trial participants to understand its safety. If the safety is acceptable, we then test the study vaccine or study medicine with a larger group of people to understand the efficacy and continue to look at safety. This series of clinical trials unfolds across four main phases.
The four phases of clinical trials
As a participant in a phase 1 clinical trial, you’ll help researchers understand the safety of a study medicine. You may have frequent clinical exams and lab work, and will be asked to report any issues or side effects.
By joining a phase 2 clinical trial, you’re helping researchers better understand how well the study medicine may work for the condition being studied, and the side effects that may occur.
In a phase 3 clinical trial, you’ll be part of a larger group of people with the medical condition being studied. Your participation helps researchers determine whether the study medicine is safe and effective for people with that condition.
Even after medicines are approved for use, you can continue to participate in long-term clinical studies designed to better understand the effects of the approved medicine over time.
Available to Patients
How clinical trials are designed
Clinical trials start with a protocol. A clinical trial protocol is a detailed plan that explains the purpose of the clinical trial and how it will be run. It includes:
the length of the clinical trial
the study medicines, procedures, and tests in the clinical trial
the schedule of study activities
information about who can participate
how side effects will be tracked, managed, and reported
the rules that must be followed
Participants are assigned to different treatment groups in a clinical trial by a process called randomization. Randomization means that participants are assigned to a treatment group by chance (like flipping a coin) rather than by choice.
Randomization is one way to help avoid bias in a study. For example, it helps ensure that people of the same sex or age are not all assigned to the same treatment group.
A controlled trial is a clinical trial that includes a comparison (control) group. In controlled clinical trials, participants are put into groups that receive the study medicine or a ‘comparator.’ We learn about the effectiveness and safety of the study medicine by comparing the experiences of the participants who receive the study medicine with those who receive the comparator.
A common example of a comparator is ‘standard of care,’ the established treatment that is currently used for a condition.
In a ‘double blind’ controlled trial, placebos are used to prevent the participant and study team from knowing whether the participant is receiving the study medicine or the comparator. A placebo does not contain any active ingredients, but the study medicine and placebo look alike. Learn more about single-blind and double-blind trials below.
Single-blind or double-blind clinical trials
Clinical trials could be single-blind or double-blind.
In a single-blind trial, the participants do not know whether they are receiving the study medicine or placebo, but the researchers know.
In double-blind trials, neither the participants nor the researchers know whether the participants are receiving the study medicine or placebo. (If necessary, such as for a safety reason, the researchers can find out what a participant has received.)
Clinical trials use blinding to help prevent bias. This way, the awareness of which treatment group a participant is in does not influence the participant or the study team.
All clinical trials are ‘unblinded,’ either after they are complete or when blinding is no longer necessary. When a study is unblinded, the assigned treatment group for each participant is revealed.